3,205 Shares in CVS Health Co. (NYSE:CVS) Bought by Fort L.P.

Fort L.P. bought a new position in shares of CVS Health Co. (NYSE:CVSFree Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,205 shares of the pharmacy operator’s stock, valued at approximately $202,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CVS. Livelsberger Financial Advisory bought a new stake in CVS Health during the 3rd quarter worth approximately $31,000. Crewe Advisors LLC acquired a new position in shares of CVS Health in the 1st quarter worth approximately $40,000. Reston Wealth Management LLC bought a new stake in CVS Health during the third quarter valued at $32,000. Kathleen S. Wright Associates Inc. bought a new position in shares of CVS Health in the 3rd quarter worth about $33,000. Finally, First Community Trust NA lifted its stake in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 1.2 %

Shares of NYSE:CVS traded down $0.65 on Friday, reaching $55.81. 13,581,795 shares of the company traded hands, compared to its average volume of 12,676,457. The stock has a market capitalization of $70.21 billion, a P/E ratio of 9.93, a price-to-earnings-growth ratio of 0.83 and a beta of 0.55. The business’s 50-day simple moving average is $59.66 and its 200 day simple moving average is $59.56. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $2.21 EPS. As a group, equities analysts anticipate that CVS Health Co. will post 6.41 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.77%. CVS Health’s dividend payout ratio is 47.33%.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of research analyst reports. Barclays cut their price target on CVS Health from $82.00 to $75.00 and set an “overweight” rating on the stock in a report on Wednesday, October 23rd. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Nine analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average price target of $73.17.

Read Our Latest Stock Report on CVS Health

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Further Reading

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.